FILE PHOTO: Vial labelled "AstraZeneca coronavirus disease (COVID-19) vaccine" placed on displayed EU flag is seen in this illustration picture taken March 24, 2021. REUTERS/Dado Ruvic/File Photo
LONDON (Reuters) - European and British regulators said on Wednesday they had found possible links between AstraZeneca's vaccine and very rare cases of blood clots, but reaffirmed its importance in protecting people against COVID-19.
A British government advisory group said the vaccine should not be given to the under 30s where possible, though an official said this was "really out of the utmost caution, rather than because we have any serious safety concerns".
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
